Guosen: Maintain "outperform the market" rating for the textile Outfits Industry. Focus on new highlights of brands and opportunities for undervalued Hong Kong stocks.

Guosen recommends focusing on companies that have the ability to increase their market share and maintain strong medium to long-term growth.

Zhitong FinanceMar 5 10:33 · Ratings

Innovent Bio (01801.HK) and Beijing Aosaikang Pharmaceutical have reached a strategic cooperation on the lung cancer targeted drug Aiyixin.

Innovent Bio (01801.HK) and Beijing Aosaikang Pharmaceutical (002755.SZ) recently signed a cooperation agreement. The two parties will achieve exclusive commercial cooperation on the third-generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) targeted drug "Icotinib Tablet" (commodity name: Oyi Xin). Beijing Aosaikang Pharmaceutical will be the holder of the marketing authorization for the collaborative product, responsible for the commercial production and supply of the collaborative product, and will pay Innovent Bio sales and marketing service fees according to the cooperation agreement. Innovent Bio will obtain the exclusive promotion and sales rights of the collaborative product in China mainland, and will pay according to the cooperation agreement

AASTOCKSOct 8, 2024 10:52

REACH NEW HLDGS: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TOTHE ANNUAL REPORT 2023

HKEXSep 27, 2024 19:31 · Announcements

REACH NEW HLDGS: INTERIM REPORT 2024

HKEXSep 24, 2024 16:36 · Announcements

Haitong Securities: Continuous destocking of polyester filament factories, expecting improvement in end demand.

As the inventory of rayon continues to decrease, Haitong Securities expects downstream demand to further improve with the approach of the traditional peak season in September and October.

Zhitong FinanceAug 27, 2024 11:18

Reach New Holdings (08471) announced its interim results, with a net loss attributable to shareholders of 6.485 million yuan, a year-on-year increase of 419.2%.

Reach New Holdings (08471) released its six-month performance for the period ending June 30, 2024, with a revenue of 39.709 million...

Zhitong FinanceAug 22, 2024 22:33